Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis

Non-alcoholic fatty liver disease (NAFLD) and its progressive stage, non-alcoholic steatohepatitis (NASH), are becoming one of the most common chronic liver diseases globally. Lifestyle interventions such as weight reduction, increased physical activity, and maintaining healthy diets play a pivotal...

Full description

Bibliographic Details
Main Authors: Yuezhi Zhu, Jen Kit Tan, Jia Liu, Jo Aan Goon
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/13/3/329
_version_ 1797242285112426496
author Yuezhi Zhu
Jen Kit Tan
Jia Liu
Jo Aan Goon
author_facet Yuezhi Zhu
Jen Kit Tan
Jia Liu
Jo Aan Goon
author_sort Yuezhi Zhu
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) and its progressive stage, non-alcoholic steatohepatitis (NASH), are becoming one of the most common chronic liver diseases globally. Lifestyle interventions such as weight reduction, increased physical activity, and maintaining healthy diets play a pivotal role in managing NAFLD/NASH. Recent studies suggest that the gut microbiome is associated with the pathogenesis of NAFLD/NASH, prompting microbiome-targeted therapy to emerge as a new therapeutic option for NAFLD/NASH. We conducted a systematic review based on the PRISMA statement and employed network meta-analysis to investigate the effects of traditional probiotics and next-generation probiotics (NGPs) on NAFLD/NASH. Comparative analysis reveals that traditional probiotics primarily reduce liver fat deposition and inflammation by improving gut microbiota composition, enhancing intestinal barrier function, and modulating immune responses. In contrast, NGPs demonstrate a more significant therapeutic potential, attributed to their direct effects on inhibiting oxidative stress and their ability to enhance the production of short-chain fatty acids (SCFAs), NGPs appear as a new potential strategy for the management of NAFLD/NASH through their dual action of directly inhibiting oxidative stress and enhancing SCFA production, highlighting the importance of understanding and utilizing the direct and indirect regulatory mechanisms of oxidative stress in the management of NAFLD/NASH.
first_indexed 2024-04-24T18:36:47Z
format Article
id doaj.art-7f008c8a771f463fab974349319a1889
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-04-24T18:36:47Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-7f008c8a771f463fab974349319a18892024-03-27T13:18:36ZengMDPI AGAntioxidants2076-39212024-03-0113332910.3390/antiox13030329Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-AnalysisYuezhi Zhu0Jen Kit Tan1Jia Liu2Jo Aan Goon3Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, MalaysiaDepartment of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, MalaysiaDepartment of Nursing, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, MalaysiaDepartment of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, MalaysiaNon-alcoholic fatty liver disease (NAFLD) and its progressive stage, non-alcoholic steatohepatitis (NASH), are becoming one of the most common chronic liver diseases globally. Lifestyle interventions such as weight reduction, increased physical activity, and maintaining healthy diets play a pivotal role in managing NAFLD/NASH. Recent studies suggest that the gut microbiome is associated with the pathogenesis of NAFLD/NASH, prompting microbiome-targeted therapy to emerge as a new therapeutic option for NAFLD/NASH. We conducted a systematic review based on the PRISMA statement and employed network meta-analysis to investigate the effects of traditional probiotics and next-generation probiotics (NGPs) on NAFLD/NASH. Comparative analysis reveals that traditional probiotics primarily reduce liver fat deposition and inflammation by improving gut microbiota composition, enhancing intestinal barrier function, and modulating immune responses. In contrast, NGPs demonstrate a more significant therapeutic potential, attributed to their direct effects on inhibiting oxidative stress and their ability to enhance the production of short-chain fatty acids (SCFAs), NGPs appear as a new potential strategy for the management of NAFLD/NASH through their dual action of directly inhibiting oxidative stress and enhancing SCFA production, highlighting the importance of understanding and utilizing the direct and indirect regulatory mechanisms of oxidative stress in the management of NAFLD/NASH.https://www.mdpi.com/2076-3921/13/3/329NAFLD/NASHtraditional probioticsnext-generation probiotics (NGPs)short-chain fatty acids (SCFAs)antioxidant
spellingShingle Yuezhi Zhu
Jen Kit Tan
Jia Liu
Jo Aan Goon
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
Antioxidants
NAFLD/NASH
traditional probiotics
next-generation probiotics (NGPs)
short-chain fatty acids (SCFAs)
antioxidant
title Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
title_full Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
title_fullStr Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
title_full_unstemmed Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
title_short Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
title_sort roles of traditional and next generation probiotics on non alcoholic fatty liver disease nafld and non alcoholic steatohepatitis nash a systematic review and network meta analysis
topic NAFLD/NASH
traditional probiotics
next-generation probiotics (NGPs)
short-chain fatty acids (SCFAs)
antioxidant
url https://www.mdpi.com/2076-3921/13/3/329
work_keys_str_mv AT yuezhizhu rolesoftraditionalandnextgenerationprobioticsonnonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashasystematicreviewandnetworkmetaanalysis
AT jenkittan rolesoftraditionalandnextgenerationprobioticsonnonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashasystematicreviewandnetworkmetaanalysis
AT jialiu rolesoftraditionalandnextgenerationprobioticsonnonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashasystematicreviewandnetworkmetaanalysis
AT joaangoon rolesoftraditionalandnextgenerationprobioticsonnonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashasystematicreviewandnetworkmetaanalysis